Impact Of Gabapentin Adjunct Use With Benzodiazepines For The Treatment Of Alcohol Withdrawal In A Psychiatric Hospital

By |2018-11-21T11:30:26+00:00November 21st, 2018|Articles In Press|

ORIGINAL RESEARCH Vadiei, N., Smith T. L., Walton, A. E., and Kjome, K. L. Abstract Introduction: Benzodiazepines are currently the gold standard for treatment of alcohol withdrawal. Gabapentin has growing evidence to support its use in the treatment of alcohol use disorder, however there is limited evidence regarding its role in [...]

Paroxetine Versus Vortioxetine For Depressive Symptoms In Postmenopausal Transition: A Preliminary Study

By |2018-11-21T11:30:38+00:00November 21st, 2018|Articles In Press|

EVIDENCE-BASED MEDICINE Callegari C, Ielmini M., Caselli I., Lucca G., Isella C., Diurni M., Pettenon F., and Poloni N. Abstract Background: The impact of menopause is a consequence of social, physical and mental changes; hormonal changes play an important role in inducing an increased risk of developing depressive symptoms. It is [...]

An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome

By |2018-11-21T11:31:54+00:00November 21st, 2018|Articles In Press|

COMPLICATED CASE HISTORIES By Roland van Rensburg and Eric H. Decloedt Abstract Neuroleptic malignant syndrome is a rare, idiosyncratic emergency associated with exposure to dopamine antagonists, commonly antipsychotic drugs. The typical clinical picture consists of altered consciousness, muscular rigidity, fever, and autonomic instability. While the condition has generally been well described, the [...]

Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case Report

By |2018-11-21T11:32:20+00:00November 21st, 2018|Articles In Press|

COMPLICATED CASE HISTORIES By Gangaparameswari Soundarrajan, Bharti Chogtu Magazine, Vybhav Krishna, Avinash Kamath G, and Manisha murugesan Abstract Akathisia is a common movement disorder that occurs as a consequence of antipsychotic therapy. However, its occurrence secondary to risperidone withdrawal has been reported rarely. Reporting of such rare adverse event gains profound importance because changing the [...]

Exercise as a Treatment for Schizophrenia: a Review

By |2018-11-21T11:32:34+00:00November 21st, 2018|Articles In Press|

GENERAL PSYCHIATRY By Steven J. Girdler, Jamie E. Confino and Mary E. Woesner Abstract Schizophrenia is a mental disorder that is characterized by progressive cognitive impairment in areas of attention, working memory, and executive functioning. Although no clear etiology of schizophrenia has been discovered, many factors have been identified that contribute to [...]

Promoting The Discussion Of The Beneficial Effects Of Ketamine To Treat Refractory Depression

By |2018-11-21T11:32:49+00:00November 21st, 2018|Articles In Press|

BRIEF REPORT Priyanka, G. and Viswanath, O. Abstract We read a recent article published by CNN titled “Ketamine offers lifeline for people with severe depression, suicidal thoughts1” with great interest. The article traces the story of a man with a 35-year history of severe refractory depression, suicidal ideation, and recent suicide [...]